Samsara BioCapital, LLC - INOZYME PHARMA INC ownership

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of INOZYME PHARMA INC
ValueSharesWeighting
Q3 2023$6,562,500
+127.1%
1,562,500
+209.8%
2.01%
+236.5%
Q1 2023$2,890,252504,4070.60%
Other shareholders
INOZYME PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,591,154$18,441,0006.52%
CHI Advisors LLC 920,264$10,666,0003.11%
Sofinnova Investments, Inc. 2,028,308$23,508,0001.39%
MPM BioImpact LLC 320,724$3,717,0000.58%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,344,786$27,176,0000.53%
NEA Management Company, LLC 2,444,379$28,330,0000.34%
Rock Springs Capital Management LP 850,015$9,852,0000.21%
SUVRETTA CAPITAL MANAGEMENT, LLC 986,400$11,432,0000.19%
Overbrook Management Corp 16,726$194,0000.04%
Orbimed Advisors 294,000$3,407,0000.04%
View complete list of INOZYME PHARMA INC shareholders